A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 164 participants.

Also called NCT05820035

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 164 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05820035
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05820035. Allocation not applicable; no masking; primary purpose treatment. Start 2023-03-09 (actual); primary completion 2024-02-23 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia
Acronym
PSVT
Condition
Paroxysmal Supraventricular Tachycardia
Condition
Atrioventricular Nodal Reentrant Tachycardia
Condition
Atrioventricular Reciprocating Tachycardia
Intervention (Device)
Pulsed Field Ablation Device and CF-Sensing Pulsed Field Ablation Catheter
Lead sponsor
Shanghai MicroPort EP MedTech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05820035
Content hash
54fb4843b6c43eacae1d0bc039a3e484b969c39d4193b66b7ba50efa37ea337c